Rat N-ERC/Mesothelin as a Marker for In Vivo Screening of Drugs against Pancreas Cancer
Figure 4
Correlation between tumor weight and serum level of N-ERC/mesothelin.
The serum level of N-ERC/mesothelin in homozygous Kras301 rats bearing pancreas ductal carcinomas. The serum level of N-ERC/mesothelin correlated with increased tumor weight (R = 0.897).